DESTINY-Breast05 is a large phase 3 trial in women with HER2-positive early-stage breast cancer who had chemotherapy and ...

LAFAYETTE PARISH — A breast cancer clinic in Lafayette is giving women in Acadiana easier access to specialized screenings, genetic risk assessments and early detection tools, the perfect highlight to ...

A new study asked whether women with an elevated risk of breast cancer were adhering to recommended MRI screening after genetic testing and counseling. Women with a BRCA mutation or other high-risk ...

The National Institute for Health and Care Excellence (NICE) has recommended ribociclib (Kisqali, Novartis) as an adjuvant treatment for early breast cancer in patients at high risk of recurrence. The ...

Interval cancers, diagnosed between screenings, often present more aggressively and are linked to breast density and hormone replacement therapy. A study found 30% of breast cancer cases in Swedish ...

WEST COLUMBIA, S.C. — Lexington Medical Center has launched a high-risk breast clinic to provide specialized support for women facing an elevated chance of developing breast cancer. While the average ...

Pennsylvania Act 1 of 2023's criteria for supplemental breast cancer screenings disproportionately exclude Black women, exacerbating existing disparities in breast cancer diagnosis. The study found ...

When it comes to breast cancer, doctors say early detection is key, especially if you are high risk. Those at high risk include people who have a family history of cancer, increased breast density, ...

Previously reported results from monarchE showed that adjuvant abemaciclib plus endocrine therapy is associated with a significant improvement in invasive disease-free survival (IDFS) over endocrine ...

What are the odds that you will get breast cancer in the next few years? Soon, AI might tell you the answer. Researchers and companies are designing artificial-intelligence models to predict a woman’s ...

Please provide your email address to receive an email when new articles are posted on . The addition of nivolumab to neoadjuvant chemotherapy significantly increased pathologic complete response among ...